Regulation of Kidney-Specific Gene Expression
肾脏特异性基因表达的调节
基本信息
- 批准号:10629391
- 负责人:
- 金额:$ 48.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-18 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAdhesivesAffectBindingBiochemicalCHD4 geneCell ProliferationCellsChIP-seqChromatin LoopChromatin Remodeling FactorComplexCouplesCyclic AMPCystCystic Kidney DiseasesDNADNA BindingDepositionDiseaseDistalEZH2 geneEnhancersEpithelial CellsEpitheliumFibrosisGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomicsGoalsGrowthHealthHi-CHistone AcetylationHistonesHumanImmunoprecipitationIndividualInheritedKidneyKidney DiseasesKidney FailureLigandsMass Spectrum AnalysisMeasuresMessenger RNAMolecularMusMutant Strains MiceMutationNamesNuRD complexOrganPathogenesisPathway interactionsPhenotypePhosphorylationPlayPolycombPolycystic Kidney DiseasesPolymeraseProteinsRNA Polymerase IIRegulationRenal functionRepressionRoleSignal PathwaySignal TransductionStructureTestingTissue-Specific Gene ExpressionTranscription ElongationTranscriptional RegulationUntranslated RNAUrinary tractWNT Signaling PathwayWNT9A geneWnt proteinsWorkautosomebeta cateninchromatin modificationchromatin remodelingchromosome conformation capturecongenital anomalies of the kidneyderepressionfibrogenesisgene repressiongenome-widehepatocyte nuclear factorhistone methylationhistone modificationimprovedin vivo evaluationindexinginsightinterstitialkidney cellkidney fibrosislipid metabolismlymphoid enhancer-binding factor 1mouse geneticsmouse modelmutantmutant mouse modelnephrogenesisnoveloverexpressionpalmitoylationpromoterrecruitrenal epitheliumtherapeutic targettraffickingtranscription factortranscriptome sequencingurinary
项目摘要
ABSTRACT
The purpose of this MERIT renewal is to continue our studies on hepatocyte nuclear factor-1β (HNF-1β) and its
roles in kidney-specific gene expression and cystic kidney diseases. HNF-1β is a DNA-binding transcription
factor that regulates tissue-specific gene expression in the kidney and other epithelial organs. Mutations of HNF-
1β produce congenital anomalies of the kidney and urinary tract, cystic kidney disease, autosomal dominant
tubulointerstitial kidney disease, and inherited tubulopathies. To unravel the pathogenesis of these disorders,
we have produced HNF-1β mutant mice that develop phenotypes similar to those seen in affected humans.
Analysis of the mutant mice has revealed that HNF-1β plays a central role in the expression of polycystic kidney
disease genes, such as PKD2 and PKHD1. During the last project period, we used genome-wide ChIP-seq and
RNA-seq to identify transcriptional networks that are directly regulated by HNF-1β. Together with new mutant
mouse models, these studies uncovered novel roles of HNF-1β in the regulation of Wnt signaling, cAMP
signaling, lipid metabolism, urinary concentration, and expression of noncoding RNAs. Preliminary studies using
mass spectrometry revealed that HNF-1β interacts with proteins involved in chromatin remodeling, histone
modification, and transcription elongation. In the next project period we will extend this work to further unravel
the functions of HNF-1β in the kidney. Specific Aim 1 will use biochemical studies to unravel the molecular
mechanisms whereby HNF-1β represses Wnt pathway genes. We will test the hypothesis that HNF-1β forms
repressive chromatin loops that exert long-range effects on histone modification, chromatin remodeling, and
transcription elongation. Specific Aim 2 will apply mouse genetics to elucidate the roles of dysregulated Wnt
signaling in the HNF-1β mutant phenotype. We will determine whether mutations of Wnt pathway genes that are
overexpressed in HNF-1β mutant mice improve kidney function and structure. Collectively, the proposed studies
will advance our understanding of gene regulation, unravel how mutations of HNF-1β produce kidney
abnormalities, and identify potential therapeutic targets for HNF-1β-related cystic kidney diseases.
抽象的
本次MERIT更新的目的是继续我们对肝细胞核因子-1β(HNF-1β)及其相关的研究
HNF-1β 是一种 DNA 结合转录,在肾脏特异性基因表达和囊性肾病中发挥作用。
调节肾脏和其他上皮器官中组织特异性基因表达的因子。
1β 产生肾脏和泌尿道先天性异常、囊性肾病、常染色体显性遗传
肾小管间质性肾病和遗传性肾小管病 为了阐明这些疾病的发病机制,
我们已经培育出 HNF-1β 突变小鼠,其表型与受影响的人类相似。
对突变小鼠的分析表明,HNF-1β在多囊肾的表达中起着核心作用
疾病基因,例如 PKD2 和 PKHD1 在上一个项目期间,我们使用了全基因组 ChIP-seq 和
RNA-seq 鉴定受 HNF-1β 和新突变体直接调控的转录网络。
小鼠模型中,这些研究揭示了 HNF-1β 在 Wnt 信号传导、cAMP 调节中的新作用
使用非编码 RNA 进行信号传导、脂质代谢、尿浓度和表达的初步研究。
质谱分析显示 HNF-1β 与参与染色质重塑的蛋白质、组蛋白相互作用
在下一个项目期间,我们将扩展这项工作以进一步阐明。
HNF-1β 在肾脏中的功能具体目标 1 将利用生化研究来阐明其分子机制。
HNF-1β 抑制 Wnt 通路基因的机制 我们将检验 HNF-1β 形成的假设。
抑制性染色质环对组蛋白修饰、染色质重塑和
具体目标 2 将应用小鼠遗传学来阐明 Wnt 失调的作用。
我们将确定 HNF-1β 突变表型中的信号传导是否是 Wnt 通路基因的突变。
总的来说,拟议的研究在 HNF-1β 突变小鼠中过度表达可改善肾功能和结构。
将增进我们对基因调控的理解,揭示 HNF-1β 突变如何产生肾脏
异常,并确定 HNF-1β 相关囊性肾病的潜在治疗靶点。
项目成果
期刊论文数量(51)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Following the expression of a kidney-specific gene from early development to adulthood.
跟踪从早期发育到成年的肾脏特异性基因的表达。
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Igarashi; Peter
- 通讯作者:Peter
Tissue-specific regulation of the mouse Pkhd1 (ARPKD) gene promoter.
小鼠 Pkhd1 (ARPKD) 基因启动子的组织特异性调控。
- DOI:
- 发表时间:2014-08-01
- 期刊:
- 影响因子:0
- 作者:Williams, Scott S;Cobo;Hajarnis, Sachin;Aboudehen, Karam;Shao, Xinli;Richardson, James A;Patel, Vishal;Igarashi, Peter
- 通讯作者:Igarashi, Peter
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.
microRNA-17家族通过调节线粒体代谢促进多囊肾病的进展。
- DOI:
- 发表时间:2017
- 期刊:
- 影响因子:16.6
- 作者:Hajarnis, Sachin;Lakhia, Ronak;Yheskel, Matanel;Williams, Darren;Sorourian, Mehran;Liu, Xueqing;Aboudehen, Karam;Zhang, Shanrong;Kersjes, Kara;Galasso, Ryan;Li, Jian;Kaimal, Vivek;Lockton, Steven;Davis, Scott;Flaten, Andrea;Johnson, Joshua
- 通讯作者:Johnson, Joshua
Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease.
转录因子肝细胞核因子-1β 在多囊肾病中的作用。
- DOI:10.1016/j.cellsig.2020.109568
- 发表时间:2020-02-14
- 期刊:
- 影响因子:4.8
- 作者:Annie Shao;S. Chan;P. Igarashi
- 通讯作者:P. Igarashi
HNF-1beta regulates transcription of the PKD modifier gene Kif12.
HNF-1beta 调节 PKD 修饰基因 Kif12 的转录。
- DOI:10.1681/asn.2008020238
- 发表时间:2024-09-14
- 期刊:
- 影响因子:0
- 作者:Yimei Gong;Zhendong Ma;V. Patel;Evelyne Fischer;T. Hiesberger;M. Pontoglio;P. Igarashi
- 通讯作者:P. Igarashi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Igarashi其他文献
Peter Igarashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Igarashi', 18)}}的其他基金
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 48.03万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7832043 - 财政年份:2009
- 资助金额:
$ 48.03万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7883980 - 财政年份:2009
- 资助金额:
$ 48.03万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 48.03万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7325171 - 财政年份:2007
- 资助金额:
$ 48.03万 - 项目类别:
UT southwestern O'Brien Kidney Research Core Center
德克萨斯大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8912182 - 财政年份:2007
- 资助金额:
$ 48.03万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8148016 - 财政年份:2007
- 资助金额:
$ 48.03万 - 项目类别:
相似国自然基金
氮杂环丙烷基聚多硫化物可逆粘合剂的分子设计与制备
- 批准号:22378080
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多酚功能化壳聚糖基组织粘合剂构建及其能量耗散机制探究
- 批准号:82302389
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
聚电解质络合作用调控的高初黏性大豆蛋白粘合剂构建及增强机制研究
- 批准号:52303059
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于短肽诱导蚕丝蛋白组装的可控粘附生物粘合剂的制备及粘附性能研究
- 批准号:52303272
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载MUR仿生脂质体粘合剂靶向调控荷菌巨噬细胞IFI204/ARMCX3/Caspase-11焦亡抑制创伤性骨髓炎发生的机制研究
- 批准号:82372421
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Unveiling Functional Roles of Apical Surface Interactions Between Opposing Cell Layers
揭示相对细胞层之间顶端表面相互作用的功能作用
- 批准号:
10629101 - 财政年份:2023
- 资助金额:
$ 48.03万 - 项目类别:
The Role of Activin-like kinase 5 (ALK5) for maintaining microglia and astrocyte homeostasis and activation
激活素样激酶 5 (ALK5) 在维持小胶质细胞和星形胶质细胞稳态和激活中的作用
- 批准号:
10388033 - 财政年份:2022
- 资助金额:
$ 48.03万 - 项目类别:
The Role of Activin-like kinase 5 (ALK5) for maintaining microglia and astrocyte homeostasis and activation
激活素样激酶 5 (ALK5) 在维持小胶质细胞和星形胶质细胞稳态和激活中的作用
- 批准号:
10839283 - 财政年份:2022
- 资助金额:
$ 48.03万 - 项目类别: